D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC

Clinical trial NCT06643208 · RECRUITING

Trial details

NCT number: NCT06643208
Sponsor: Fujian Provincial Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Intrahepatic Cholangiocarcinoma

Start date: 2024-07-01
Primary completion: 2027-01-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.